Efficacy of the alkalizers on CKD(CKOALA study)
Not Applicable
- Conditions
- D007676Chronic kidney disease
- Registration Number
- JPRN-jRCTs021180043
- Lead Sponsor
- Abe Michiaki
- Brief Summary
There are no changes on primary endpoint. For secondary endpoint, treatment by sodium/potassium citrate could increase morning-urine pH and might improve serum creatinine and eGFR-Cr. The limitation of the study is low number of the registration.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
1) A patient with chronic kidney disease and age >= 20, < 81 years.
2) Signed and dated informed consent document indicating that patient has been informed of all pertinent aspects of this trial prior to enrollment.
Exclusion Criteria
1) Serious heart disease or liver disease.
2) Patients with alkaline urine.
3) Patients who are judged unfit to enroll in this trial by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum creatinine level, eGFR, protein urea,cardiovascular disease.
- Secondary Outcome Measures
Name Time Method rinary surrogate marker.